{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:10:46Z","timestamp":1777453846723,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12253-016-0053-x","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T22:43:37Z","timestamp":1457649817000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oxidative Stress, DNA, Cell Cycle\/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"22","author":[{"given":"A. C.","family":"Mamede","sequence":"first","affiliation":[]},{"given":"S.","family":"Guerra","sequence":"additional","affiliation":[]},{"given":"M.","family":"Laranjo","sequence":"additional","affiliation":[]},{"given":"K.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"M. J.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"T.","family":"Carvalheiro","sequence":"additional","affiliation":[]},{"given":"P.","family":"Moura","sequence":"additional","affiliation":[]},{"given":"A.","family":"Paiva","sequence":"additional","affiliation":[]},{"given":"A. M.","family":"Abrantes","sequence":"additional","affiliation":[]},{"given":"C. J.","family":"Maia","sequence":"additional","affiliation":[]},{"given":"M. F.","family":"Botelho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1254\/jphs.CR0070034","volume":"105","author":"A Toda","year":"2007","unstructured":"Toda A, Okabe M, Yoshida T, Nikaido T (2007) The potential of amniotic membrane\/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 105:215\u2013228","journal-title":"J Pharmacol Sci"},{"key":"53_CR2","first-page":"307","volume":"15","author":"J Davis","year":"1910","unstructured":"Davis J (1910) Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J 15:307","journal-title":"Johns Hopkins Med J"},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.icu.0000172827.31985.3a","volume":"16","author":"J Gomes","year":"2005","unstructured":"Gomes J, Romano A, Santos M, Dua H (2005) Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol 16:233\u2013240","journal-title":"Curr Opin Ophthalmol"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjo.83.6.748","volume":"83","author":"H Dua","year":"1999","unstructured":"Dua H, Azuara-Blanco A (1999) Amniotic membrane transplantation. Br J Ophthalmol 83:748\u2013752","journal-title":"Br J Ophthalmol"},{"key":"53_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0305-4179(89)90015-6","volume":"15","author":"C Sawhney","year":"1989","unstructured":"Sawhney C (1989) Amniotic membrane as a biological dressing in the management of burns. Burns 15:339\u2013342","journal-title":"Burns"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00441-012-1424-6","volume":"349","author":"A Mamede","year":"2012","unstructured":"Mamede A, Carvalho M, Abrantes A, et al. (2012) Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res 349:447\u2013458","journal-title":"Cell Tissue Res"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1582-4934.2012.01531.x","volume":"16","author":"M Magatti","year":"2012","unstructured":"Magatti M, De Munari S, Vertua E, Parolini O (2012) Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. J Cell Mol Med 16:2208\u20132218","journal-title":"J Cell Mol Med"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11033-011-0760-z","volume":"39","author":"H Jiao","year":"2012","unstructured":"Jiao H, Guan F, Yang B, et al. (2012) Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the bcl-2\/caspase pathways. Mol Biol Rep 39:467\u2013473","journal-title":"Mol Biol Rep"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/13685538.2014.896894","volume":"17","author":"A Rolfo","year":"2014","unstructured":"Rolfo A, Giuffrida D, Giuffrida M, et al. (2014) New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media. Aging Male 17:94\u2013101","journal-title":"Aging Male"},{"key":"53_CR10","first-page":"2022","volume":"40","author":"N-H Kang","year":"2012","unstructured":"Kang N-H, Yi B-R, Lim S, et al. (2012) Human amniotic membrane-derived epithelial stem cells display anticancer activity in BALB\/c female nude mice bearing disseminated breast cancer xenografts. Int J Oncol 40:2022\u20132028","journal-title":"Int J Oncol"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcyt.2013.07.005","volume":"16","author":"H Niknejad","year":"2014","unstructured":"Niknejad H, Khayat-Khoei M, Peirovi H, Abolghasemi H (2014) Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy. Cytotherapy 16:33\u201340","journal-title":"Cytotherapy"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00232-014-9642-3","volume":"247","author":"A Mamede","year":"2014","unstructured":"Mamede A, Laranjo M, Carvalho M, et al. (2014) Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study. J Membr Biol 247:357\u2013360","journal-title":"J Membr Biol"},{"key":"53_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12032-015-0702-z","volume":"32","author":"A Mamede","year":"2015","unstructured":"Mamede A, Guerra S, Laranjo M, et al. (2015) Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma. Med Oncol 32:257","journal-title":"Med Oncol"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ramb.2013.03.005","volume":"59","author":"M Gomes","year":"2013","unstructured":"Gomes M, Priolli D, Tralh\u00e3o J, Botelho M (2013) Hepatocellular carcinoma: epidemiology, biology, diagnosis and therapies. Rev Assoc Med Bras 59:514\u2013524","journal-title":"Rev Assoc Med Bras"},{"key":"53_CR15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374\u20131403","journal-title":"Eur J Cancer"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-9-171","volume":"9","author":"M Marra","year":"2011","unstructured":"Marra M, Sordelli I, Lombardi A, et al. (2011) Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med 9:171","journal-title":"J Transl Med"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1665-2681(19)31582-0","volume":"10","author":"R Alves","year":"2011","unstructured":"Alves R, Alves D, Guz B, et al. (2011) Advanced hepatocellular carcinoma: review of targeted molecular drugs. Ann Hepatol 10:21\u201327","journal-title":"Ann Hepatol"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000343656","volume":"58","author":"A Brito","year":"2013","unstructured":"Brito A, Abrantes A, Pinto-Costa C, et al. (2013) Hepatocellular carcinoma and chemotherapy: the role of p53. Chemotherapy 58:381\u2013386","journal-title":"Chemotherapy"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/ans.12201","volume":"84","author":"J Tralh\u00e3o","year":"2013","unstructured":"Tralh\u00e3o J, Abrantes A, Hoti E, et al. (2013) Hepatectomy and liver regeneration: from experimental research to clinical application. ANZ J Surg 84:665\u2013671","journal-title":"ANZ J Surg"},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nucmedbio.2009.11.001","volume":"37","author":"A Abrantes","year":"2010","unstructured":"Abrantes A, Serra M, Gon\u00e7alves A, et al. (2010) Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells. Nucl Med Biol 37:125\u2013132","journal-title":"Nucl Med Biol"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0102-86502013000900006","volume":"28","author":"J Tralh\u00e3o","year":"2013","unstructured":"Tralh\u00e3o J, Abrantes A, Gon\u00e7alves A, et al. (2013) Study of hepatocellular function in the murine model following hepatic artery selective clamping. Acta Cir Bras 28:657\u2013663","journal-title":"Acta Cir Bras"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jbbm.2005.10.003","volume":"65","author":"A Gomes","year":"2005","unstructured":"Gomes A, Fernandes E, Lima J (2005) Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 65:45\u201380","journal-title":"J Biochem Biophys Methods"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/01635581.2012.713539","volume":"64","author":"A Mamede","year":"2012","unstructured":"Mamede A, Pires A, Abrantes A, et al. (2012) Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies. Nutr Cancer 64:1049\u20131057","journal-title":"Nutr Cancer"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/35.2.2432118","volume":"35","author":"A Larrauri","year":"1987","unstructured":"Larrauri A, L\u00f3pez P, G\u00f3mez-Lech\u00f3n M, Castell J (1987) A cytochemical stain for glutathione in rat hepatocytes cultured on plastic. J Histochem Cytochem 35:271\u2013274","journal-title":"J Histochem Cytochem"},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/nar\/24.5.992","volume":"24","author":"Y Ioannou","year":"1996","unstructured":"Ioannou Y, Chen F (1996) Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res 24:992\u2013993","journal-title":"Nucleic Acids Res"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2014.04.008","volume":"79","author":"K Santos","year":"2014","unstructured":"Santos K, Laranjo M, Abrantes A, et al. (2014) Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. Eur J Med Chem 79:273\u2013281","journal-title":"Eur J Med Chem"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2012.04.003","volume":"53","author":"A Serra","year":"2012","unstructured":"Serra A, Am RG, Laranjo M, et al. (2012) Synthesis of new 2-galactosylthiazolidine-4-carboxylic acid amides. antitumor evaluation against melanoma and breast cancer cells. Eur J Med Chem 53:398\u2013402","journal-title":"Eur J Med Chem"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jceh.2015.05.003","volume":"5","author":"A Brito","year":"2015","unstructured":"Brito A, Abrantes A, Ribeiro M, et al. (2015) Fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma: correlation with glucose transporters and p53 expression. J Clin Exp Hepatol 5:183\u2013189","journal-title":"J Clin Exp Hepatol"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3350\/cmh.2015.21.3.257","volume":"21","author":"A Gomes","year":"2015","unstructured":"Gomes A, Abrantes A, Brito A, et al. (2015) P53 influence on the radiotherapy response of hepatocellular carcinoma. Clin Mol Hepatol 21:257\u2013267","journal-title":"Clin Mol Hepatol"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40291-014-0106-3","volume":"18","author":"A Brito","year":"2014","unstructured":"Brito A, Mendes M, Abrantes A, et al. (2014) Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)fluoro-d-glucose. Mol Diagn Ther 18:495\u2013504","journal-title":"Mol Diagn Ther"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4236\/jct.2011.23056","volume":"02","author":"J Casalta-Lopes","year":"2011","unstructured":"Casalta-Lopes J, Abrantes A, Laranjo M, et al. (2011) Efflux pumps modulation in colorectal adenocarcinoma cell lines: the role of nuclear medicine. J Cancer Ther 02:408\u2013417","journal-title":"J Cancer Ther"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720209789630375","volume":"6","author":"K Choi","year":"2009","unstructured":"Choi K, Kim J, Kim G, Choi C (2009) Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr Neurovasc Res 6:213\u2013222","journal-title":"Curr Neurovasc Res"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44\u201384","journal-title":"Int J Biochem Cell Biol"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/jn\/137.10.2171","volume":"137","author":"Y Li","year":"2007","unstructured":"Li Y, Schellhorn H (2007) New developments and novel therapeutic perspectives for vitamin C. J Nutr 137:2171\u20132184","journal-title":"J Nutr"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nprot.2008.222","volume":"4","author":"C Georgiou","year":"2009","unstructured":"Georgiou C, Papapostolou I, Grintzalis K (2009) Protocol for the quantitative assessment of DNA concentration and damage (fragmentation and nicks). Nat Protoc 4:125\u2013131","journal-title":"Nat Protoc"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta S, Chaturvedi M, Aggarwal B (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603\u20131616","journal-title":"Free Radic Biol Med"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1002\/j.1460-2075.1993.tb06042.x","volume":"12","author":"F Oberhammer","year":"1993","unstructured":"Oberhammer F, Wilson J, Dive C, et al. (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and\/or 50\u00a0kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679\u20133684","journal-title":"EMBO J"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.0.CO;2-H","volume":"23","author":"L Zamai","year":"1996","unstructured":"Zamai L, Falcieri E, Marhefka G, Vitale M (1996) Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 23:303\u2013311","journal-title":"Cytometry"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1101\/gad.9.8.935","volume":"9","author":"K Macleod","year":"1995","unstructured":"Macleod K, Sherry N, Hannon G, et al. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935\u2013944","journal-title":"Genes Dev"},{"key":"53_CR40","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","volume":"26","author":"S Hussain","year":"2007","unstructured":"Hussain S, Schwank J, Staib F, et al. (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166\u20132176","journal-title":"Oncogene"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.onc.1201543","volume":"16","author":"C Cayrol","year":"1998","unstructured":"Cayrol C, Knibiehler M, Ducommun B (1998) p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16:311\u2013320","journal-title":"Oncogene"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1074\/jbc.M112.353201","volume":"287","author":"C Punchihewa","year":"2012","unstructured":"Punchihewa C, Inoue A, Hishiki A, et al. (2012) Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication. J Biol Chem 287:14289\u201314300","journal-title":"J Biol Chem"},{"key":"53_CR43","first-page":"51","volume-title":"Checkp","author":"G Stark","year":"2004","unstructured":"Stark G, Taylor W (2004) Analyzing the G2\/M checkpoint. In: Schonthal AH (ed) Checkp. Control. cancer Rev. Model Syst. Humana Press, Totowa, pp. 51\u201382"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-13-167","volume":"13","author":"G Wu","year":"2013","unstructured":"Wu G, Xu L, Lin N, Liu B (2013) UCN-01 induces S and G2\/M cell cycle arrest through the p53\/p21waf1 or CHK2\/CDC25C pathways and can suppress invasion in human hepatoma cell lines. BMC Cancer 13:167","journal-title":"BMC Cancer"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00280-004-0767-4","volume":"53","author":"K-T Chan","year":"2004","unstructured":"Chan K-T, Lung M (2004) Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line. Cancer Chemother Pharmacol 53:519\u2013526","journal-title":"Cancer Chemother Pharmacol"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00280-002-0551-2","volume":"51","author":"W-P Tsang","year":"2003","unstructured":"Tsang W-P, Chau S, Fung K-P, et al. (2003) Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in saos-2 cells. Cancer Chemother Pharmacol 51:161\u2013166","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0053-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0053-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:32:48Z","timestamp":1600302768000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0053-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0053-x","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]}}}